Genetic instabilities in human cancers - PubMed (original) (raw)
Review
. 1998 Dec 17;396(6712):643-9.
doi: 10.1038/25292.
Affiliations
- PMID: 9872311
- DOI: 10.1038/25292
Review
Genetic instabilities in human cancers
C Lengauer et al. Nature. 1998.
Abstract
Whether and how human tumours are genetically unstable has been debated for decades. There is now evidence that most cancers may indeed be genetically unstable, but that the instability exists at two distinct levels. In a small subset of tumours, the instability is observed at the nucleotide level and results in base substitutions or deletions or insertions of a few nucleotides. In most other cancers, the instability is observed at the chromosome level, resulting in losses and gains of whole chromosomes or large portions thereof. Recognition and comparison of these instabilities are leading to new insights into tumour pathogenesis.
Similar articles
- Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes.
De Angelis PM, Clausen OP, Schjølberg A, Stokke T. De Angelis PM, et al. Br J Cancer. 1999 May;80(3-4):526-35. doi: 10.1038/sj.bjc.6690388. Br J Cancer. 1999. PMID: 10408863 Free PMC article. - Array-CGH analysis of microsatellite-stable, near-diploid bowel cancers and comparison with other types of colorectal carcinoma.
Jones AM, Douglas EJ, Halford SE, Fiegler H, Gorman PA, Roylance RR, Carter NP, Tomlinson IP. Jones AM, et al. Oncogene. 2005 Jan 6;24(1):118-29. doi: 10.1038/sj.onc.1208194. Oncogene. 2005. PMID: 15531920 - Telomeres and chromosome instability.
Murnane JP. Murnane JP. DNA Repair (Amst). 2006 Sep 8;5(9-10):1082-92. doi: 10.1016/j.dnarep.2006.05.030. Epub 2006 Jun 19. DNA Repair (Amst). 2006. PMID: 16784900 Review. - Chromosome rearrangements resulting from telomere dysfunction and their role in cancer.
Murnane JP, Sabatier L. Murnane JP, et al. Bioessays. 2004 Nov;26(11):1164-74. doi: 10.1002/bies.20125. Bioessays. 2004. PMID: 15499579 Review. - Mechanisms of chromosome instability in cancers.
Jefford CE, Irminger-Finger I. Jefford CE, et al. Crit Rev Oncol Hematol. 2006 Jul;59(1):1-14. doi: 10.1016/j.critrevonc.2006.02.005. Epub 2006 Apr 4. Crit Rev Oncol Hematol. 2006. PMID: 16600619 Review.
Cited by
- Preventive evolutionary medicine of cancers.
Hochberg ME, Thomas F, Assenat E, Hibner U. Hochberg ME, et al. Evol Appl. 2013 Jan;6(1):134-43. doi: 10.1111/eva.12033. Epub 2012 Dec 5. Evol Appl. 2013. PMID: 23396860 Free PMC article. - EPMA position paper in cancer: current overview and future perspectives.
Grech G, Zhan X, Yoo BC, Bubnov R, Hagan S, Danesi R, Vittadini G, Desiderio DM. Grech G, et al. EPMA J. 2015 Apr 15;6(1):9. doi: 10.1186/s13167-015-0030-6. eCollection 2015. EPMA J. 2015. PMID: 25908947 Free PMC article. - Phosphorylation of EB2 by Aurora B and CDK1 ensures mitotic progression and genome stability.
Iimori M, Watanabe S, Kiyonari S, Matsuoka K, Sakasai R, Saeki H, Oki E, Kitao H, Maehara Y. Iimori M, et al. Nat Commun. 2016 Mar 31;7:11117. doi: 10.1038/ncomms11117. Nat Commun. 2016. PMID: 27030108 Free PMC article. - Polo kinase Cdc5 associates with centromeres to facilitate the removal of centromeric cohesin during mitosis.
Mishra PK, Ciftci-Yilmaz S, Reynolds D, Au WC, Boeckmann L, Dittman LE, Jowhar Z, Pachpor T, Yeh E, Baker RE, Hoyt MA, D'Amours D, Bloom K, Basrai MA. Mishra PK, et al. Mol Biol Cell. 2016 Jul 15;27(14):2286-300. doi: 10.1091/mbc.E16-01-0004. Epub 2016 May 25. Mol Biol Cell. 2016. PMID: 27226485 Free PMC article. - Magnetic particle targeting for diagnosis and therapy of lung cancers.
Saadat M, Manshadi MKD, Mohammadi M, Zare MJ, Zarei M, Kamali R, Sanati-Nezhad A. Saadat M, et al. J Control Release. 2020 Dec 10;328:776-791. doi: 10.1016/j.jconrel.2020.09.017. Epub 2020 Sep 11. J Control Release. 2020. PMID: 32920079 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources